Is Arm Holdings a Buy Near $347? The Case for Double-Digit Upside

Arm (NASDAQ:ARM | ARM Price Prediction) has been one of the wildest rides in semiconductors this year, and the question on every shareholder’s mind is whether the current run still has gas in the tank. After a vertical move off the spring lows, ARM trades at $347.57, and our proprietary model still sees room to push higher over the next 12 months.

Our 24/7 Wall St. price target for Arm is $382.24, implying 9.98% upside from here. Our recommendation is buy, and our confidence in the call is high at 90%.

24/7 Wall St. Price Target Summary

A Vertical Year Meets a Sharp Reset

Arm is up 228.5% year to date and 129.58% over the past year, but the last week tells a different story, with shares down 14.28% after testing $418.88. ARM now sits 39% below its 52-week high of $452.70.

The fundamental backdrop, however, is improving. Q4 FY2026 revenue hit $1.49 billion, up 20.06% YoY, with non-GAAP EPS of $0.60 beating consensus by 3.57%. Full year FY2026 revenue reached $4.92 billion, with free cash flow exploding 395.51% to $882 million.

Why Bulls See $463 In Play

Bulls argue Arm is the picks-and-shovels play of the AI build out. CEO Rene Haas noted “demand for Arm AGI CPU, Arm’s first data center chip, has exceeded expectations, reinforcing Arm as the compute platform for the AI era.” Customer demand for AGI CPU exceeds $2 billion across FY2027 to FY2028, with the data center CPU opportunity sized at over $100 billion by 2030.

Hyperscaler wins read like a who’s who: NVIDIA Vera, Microsoft Cobalt, Google Axion, AWS Graviton (a $20 billion business growing triple digits), plus Meta as a multi-generation AGI CPU lead partner. Our bull case 12-month scenario reaches $463.25, or 33.28% upside, with a peak of $479.11.

The Risks Worth Watching

The bear case starts with valuation. ARM trades at a 474 trailing P/E and 185 forward P/E. The Wall Street consensus analyst target of $278.29 sits well below current levels. Operating margin compressed from 52.8% to 49.1% as R&D spending jumped 43% to $1.911 billion.

Bulls would counter that this margin compression reflects engineering ramp tied directly to the AGI CPU roadmap, not lost pricing power. Still, the Qualcomm/Nuvia trial expected Q4 calendar 2026, U.S.-China export controls, and SoftBank overhang are real. Our bear case 12-month price is $294.57, a 15.25% drawdown.

The 24/7 Wall St. Take, With Caveats

The 24/7 Wall St. price target of $382.24 backs a buy rating at 90% confidence. The factor that tips the scale is royalty acceleration: data center royalty revenue more than doubled YoY in Q4, and that mix shift is what justifies a premium multiple.

The thesis strengthens if Q1 FY2027 lands at the high end of $1.26 billion guidance, and weakens if forward EPS estimates roll lower into the Qualcomm verdict.

Looking further ahead, here is where our model projects Arm could trade, assuming current trajectories hold.

These projections assume Arm continues converting AGI CPU demand into royalty revenue. Significant upside or downside could come from hyperscaler capex shifts or an adverse Qualcomm ruling.